secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eton Pharmaceuticals, Inc. (ETON)
CIK:        0001710340
Form:       8-K
Filed at:   2024-12-12T23:59:59+00:00
Accession:  0001437749-24-037367
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eton Pharmaceuticals raises $7.0M in registered direct offering of 583,334 shares at $12.00/share
--------------------------------------------------------------------------------

- Entered Securities Purchase Agreement on Dec 10, 2024 with an institutional investor.
- Gross proceeds approximately $7.0 million from sale of 583,334 shares at $12.00 per share.
- No placement agent; shares offered under effective S-3 registration statement.
- Proceeds intended for funding acquisition opportunities for products or product candidates.
- Shares will be issued free of restrictive legends.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1710340/000143774924037367/0001437749-24-037367-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1710340/000143774924037367/eton20241211_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-037367

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer